Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Appointed director
CC transcript
Genesis Healthcare, Inc. (GEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/02/2021 GN Genesis HealthCare Announces Resident and Staff COVID-19 Vaccine Acceptance Rates
01/05/2021 GN Genesis HealthCare Announces Leadership Change
12/23/2020 GN Franklin Woods Center Among the First Long-Term Care Facilities in Maryland to Vaccinate Residents and Healthcare Workers
12/17/2020 GN Silver Lake Center, Affiliated with Genesis HealthCare, Among the First Long-Term Care Facilities in the U.S. to Administer COVID-19 Vaccine to Frontline Healthcare Workers
11/09/2020 GN Genesis Healthcare Reports Third Quarter 2020 Results
11/06/2020 GN Genesis Healthcare to Release Third Quarter 2020 Results and Provide COVID-19 Update
10/13/2020 GN LTC ACO Receives Positive Reconciliation and Settlement Under the Medicare Shared Savings Program (MSSP)
08/10/2020 GN Genesis HealthCare Reports Second Quarter 2020 Results
08/05/2020 GN Genesis Healthcare to Release Second Quarter 2020 Results and Provide COVID-19 Update
07/23/2020 GN Eight Genesis HealthCare Facilities Receive New American Heart Association Post-Acute Care Heart Failure Center Certification
03/14/2018 GN Genesis to Present at the Barclays Global Healthcare Conference on March 15, 2018; Expects to Release Fourth Quarter and Year End 2017 Results on March 16, 2018
03/08/2018 GN Genmab A/S Summons Annual General Meeting
03/06/2018 GN Genesis HealthCare Closes on Previously Announced Financing Commitments
03/01/2018 GN Genesis HealthCare Regains Compliance With NYSE Continued Listing Standard
03/01/2018 GN Selskabsvedtægter for Genmab A/S
03/01/2018 GN Articles of Association for Genmab A/S
02/28/2018 GN Capital Increase in Genmab as a Result of Employee Warrant Exercise
02/21/2018 GN Genesis Announces New Financing Commitments and Provides Updates to Previously Announced Restructuring Plans
02/21/2018 GN Genmab 2017 Annual Report
01/22/2018 GN Genmab Announces Novartis' Intention to Transition Arzerra® (ofatumumab) from Commercial Availability to Limited Availability via Compassionate Use Programs for the Treatment of CLL in Non-US Markets
01/19/2018 GN U.S. FDA Grants Priority Review for Daratumumab in Front Line Multiple Myeloma
01/16/2018 GN Genesis HealthCare Raises Over $222,000 as a Gold Level National Team for Alzheimer's Association Walk to End Alzheimer's®
01/09/2018 GN Major Shareholder Announcement
01/02/2018 GN Genmab to Present at the 36th Annual J.P. Morgan Healthcare Conference
12/15/2017 GN Grant of Restricted Stock Units to Board Members, Management and Employees and Grant of Warrants to Management and Employees in Genmab
12/11/2017 GN 156 Genesis HealthCare Sites Earn National Quality Improvement Recognition
12/11/2017 GN Genmab's 2017 R&D Update
12/04/2017 GN Genmab to Hold 2017 R&D Update
11/29/2017 GN Genesis Healthcare, Inc. Receives Continued Listing Standard Notice From the NYSE
11/29/2017 GN Genmab Achieves USD 20 Million Milestone in Daratumumab Collaboration with Janssen and Updates Financial Guidance
11/21/2017 GN Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Front Line Multiple Myeloma
11/21/2017 GN Data from Phase III ALCYONE Study of Daratumumab Accepted for Oral Presentation at Annual Meeting of the American Society of Hematology
11/16/2017 GN Genmab Achieves USD 50 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
11/15/2017 GN Selskabsvedtægter for Genmab A/S
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy